如题。重新调整IP地址，图书馆进不去，麻烦各位了！急用！万分感激！
1. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interl eukin-12 burst secretion.
Cancer Research [Cancer Res] 2007 Feb 15; Vol. 67 (4), pp. 1842-52. Date of Electronic Publicati on: 2007 Feb 09.
2. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.
Laboratory Investigation; A Journal Of Technical Methods And Pathology [Lab Invest] 2007 Jun; Vol. 87 (6), pp. 582-90. Date of Electronic Publication: 2007 Mar 19.
3. Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.
Cancer Research [Cancer Res] 2007 Jun 15; Vol. 67 (12), pp. 5929-39.
4. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Cancer Research [Cancer Res] 2007 Sep 15; Vol. 67 (18), pp. 8865-73.
5. Immunotherapy and immunoescape in colorectal cancer
World Journal Of Gastroenterology: WJG [World J Gastroenterol] 2007 Nov 28; Vol. 13 (44), pp. 5822-31.
6. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer.
Journal Of Hepatology [J Hepatol] 2007 Dec; Vol. 47 (6), pp. 807-15. Date of Electronic Publication: 2007 Oct 01.
7. SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
Proceedings Of The National Academy Of Sciences Of The United States Of America [Proc Natl Acad Sci U S A] 2008 Mar 4; Vol. 105 (9), pp. 3509-14. Date of Electronic Publication: 2008 Feb 26.
